Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Cervical Neoplasms 3Ganglioneuroblastoma 3Vaginal Neoplasms 2Neuroblastoma 2Wilms Tumor 1Thoracic Diseases 1Testicular Neoplasms 1Teratoma 1Skin Neoplasms 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Recurrence 1Pancreatic Neoplasms 1Pancreatic Intraductal Neoplasms 1Ovarian Germ Cell Cancer 1Lung Neoplasms 1Gliosarcoma 1Glioma 1Glioblastoma 1Endodermal Sinus Tumor 1Diffuse Intrinsic Pontine Glioma 1Central Nervous System Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Endometrioid 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

rucaparib 1olaparib 1durvalumab 1copanlisib 1cediranib 1capivasertib 1cabozantinib 1adavosertib 1Specimen Handling 1Radiation 1Platinum 1Nivolumab 1Immunoglobulin G 1Fluid Therapy 1Disulfides 1Congresses as Topic 1Cisplatin 1Biopsy 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Carcinoma, Endometrioid × Congresses as Topic × Clear all
NCT03345784 2024-02-20

Testing AZD1775 inC Combination With Radiotherapy and Chemotherapy in Cervical, Upper Vaginal and Uterine Cancers

National Cancer Institute (NCI)

Phase 1 Terminated
10 enrolled 15 charts
Gynecologic

Uterine Cervical Neoplasms, Vaginal Neoplasms, Carcinoma, Endometrioid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡